JelenaKunovacMD

Clinical Trials

• Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression Start of enrollment: 2010 Nov 01

  Completed

  Phase 2

• Bipolar Maintenance Study of Lurasidone Adjunctive to Lithium or Divalproex Start of enrollment: 2011 Jun 01

  Completed

  Phase 3

• Study of the Effectiveness of Three Different Doses of OPC-34712 in the Treatment of Adults With Acute Schizophrenia Start of enrollment: 2011 Jul 01

  Completed

  Phase 3

• Safety and Tolerability Study of Oral OPC-34712 as Maintenance Treatment in Adults With Schizophrenia Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• Major Depressive Disorder With Mixed Features Start of enrollment: 2012 Jan 01

  Withdrawn

  Phase 3

• PEARL Schizophrenia Maintenance Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 Start of enrollment: 2012 Jun 01

  Completed

  Phase 3

• Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients Start of enrollment: 2014 Apr 01

  Completed

  Phase 3

• Open-label Safety Study in Adults With ADHD Start of enrollment: 2014 Jun 01

  Completed

  Phase 3

• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01

  Completed

  Phase 2

• Join now to see all